|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
19:2270-2279
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of the Axin-adenomatous polyposis coli interaction.
|
|
K.E.Spink,
P.Polakis,
W.I.Weis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Axin and the adenomatous polyposis coli (APC) tumor suppressor protein are
components of the Wnt/Wingless growth factor signaling pathway. In the absence
of Wnt signal, Axin and APC regulate cytoplasmic levels of the proto-oncogene
beta-catenin through the formation of a large complex containing these three
proteins, glycogen synthase kinase 3beta (GSK3beta) and several other proteins.
Both Axin and APC are known to be critical for beta-catenin regulation, and
truncations in APC that eliminate the Axin-binding site result in human cancers.
A protease-resistant domain of Axin that contains the APC-binding site is a
member of the regulators of G-protein signaling (RGS) superfamily. The crystal
structures of this domain alone and in complex with an Axin-binding sequence
from APC reveal that the Axin-APC interaction occurs at a conserved groove on a
face of the protein that is distinct from the G-protein interface of classical
RGS proteins. The molecular interactions observed in the Axin-APC complex
provide a rationale for the evolutionary conservation seen in both proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4 Structure of Axin-RGS. (A) Final Axin-RGS 2F[o] - F[c]
-calc
electron density map in the region of surface-exposed, conserved
residues Phe156 and Gly160. The map is contoured at 1.2 .
(B) Comparison of Axin-RGS with RGS4. Axin-RGS is red, RGS4 is
gray. Helices are labeled as in Figure 3B. The additional helix
of Axin-RGS ( 5a)
and the turn of the -helix
( )
are indicated.
|
 |
Figure 5.
Figure 5 Structure of the RGS–SAMP3 complex. (A) Final
RGS–SAMP3 2F[o] - F[c] -calc
electron density map in the region of SAMP3 residues
Cys2043–Pro2049. The map is contoured at 1 .
(B) The SAMP3-binding site of Axin-RGS is distinct from the G[i
]-binding
site of RGS4. The Axin-RGS–SAMP3 complex is superimposed on
the structure of the RGS4–G[i ]complex.
Axin-RGS is red, SAMP3 is blue, RGS4 is light gray and G[i ]is
dark gray. The complex is rotated 90° perpendicular to the
page, then 180° around the vertical relative to the
orientation of Axin-RGS in Figure 4B. (C) Conservation of the
APC-binding surface of Axin-RGS. Surface representation of
Axin-RGS, colored by conservation of residues within Axin family
members. White indicates that a residue is not significantly
conserved, yellow and orange indicate residues that are
conserved or conservatively substituted, and red indicates
residues that are absolutely conserved in Axin homologs. The
SAMP3 peptide C[ ]trace
is drawn in blue. The second conserved patch referred to in the
text is visible near the top of Axin-RGS, above the
SAMP3-binding site. The complex is rotated 180° around the
horizontal relative to its orientation in (B).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2000,
19,
2270-2279)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Adamska,
C.Larroux,
M.Adamski,
K.Green,
E.Lovas,
D.Koop,
G.S.Richards,
C.Zwafink,
and
B.M.Degnan
(2010).
Structure and expression of conserved Wnt pathway components in the demosponge Amphimedon queenslandica.
|
| |
Evol Dev,
12,
494-518.
|
 |
|
|
|
|
 |
R.A.Phelps,
S.Chidester,
S.Dehghanizadeh,
J.Phelps,
I.T.Sandoval,
K.Rai,
T.Broadbent,
S.Sarkar,
R.W.Burt,
and
D.A.Jones
(2009).
A two-step model for colon adenoma initiation and progression caused by APC loss.
|
| |
Cell,
137,
623-634.
|
 |
|
|
|
|
 |
C.Matsui,
S.Kaieda,
T.Ikegami,
and
Y.Mimori-Kiyosue
(2008).
Identification of a Link between the SAMP Repeats of Adenomatous Polyposis Coli Tumor Suppressor and the Src Homology 3 Domain of DDEF.
|
| |
J Biol Chem,
283,
33006-33020.
|
 |
|
|
|
|
 |
M.S.Cortese,
V.N.Uversky,
and
A.K.Dunker
(2008).
Intrinsic disorder in scaffold proteins: getting more from less.
|
| |
Prog Biophys Mol Biol,
98,
85.
|
 |
|
|
|
|
 |
P.Radivojac,
P.H.Baenziger,
M.G.Kann,
M.E.Mort,
M.W.Hahn,
and
S.D.Mooney
(2008).
Gain and loss of phosphorylation sites in human cancer.
|
| |
Bioinformatics,
24,
i241-i247.
|
 |
|
|
|
|
 |
R.W.Cho,
X.Wang,
M.Diehn,
K.Shedden,
G.Y.Chen,
G.Sherlock,
A.Gurney,
J.Lewicki,
and
M.F.Clarke
(2008).
Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
|
| |
Stem Cells,
26,
364-371.
|
 |
|
|
|
|
 |
X.Chen,
J.Yang,
P.M.Evans,
and
C.Liu
(2008).
Wnt signaling: the good and the bad.
|
| |
Acta Biochim Biophys Sin (Shanghai),
40,
577-594.
|
 |
|
|
|
|
 |
H.B.Zhang,
C.P.Ren,
X.Y.Yang,
L.Wang,
H.Li,
M.Zhao,
H.Yang,
and
K.T.Yao
(2007).
Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues.
|
| |
Histochem Cell Biol,
127,
347-354.
|
 |
|
|
|
|
 |
M.Ritco-Vonsovici,
A.Ababou,
and
M.Horton
(2007).
Molecular plasticity of beta-catenin: new insights from single-molecule measurements and MD simulation.
|
| |
Protein Sci,
16,
1984-1998.
|
 |
|
|
|
|
 |
A.Schulenburg,
H.Ulrich-Pur,
D.Thurnher,
B.Erovic,
S.Florian,
W.R.Sperr,
P.Kalhs,
B.Marian,
F.Wrba,
C.C.Zielinski,
and
P.Valent
(2006).
Neoplastic stem cells: a novel therapeutic target in clinical oncology.
|
| |
Cancer,
107,
2512-2520.
|
 |
|
|
|
|
 |
D.Kimelman,
and
W.Xu
(2006).
beta-catenin destruction complex: insights and questions from a structural perspective.
|
| |
Oncogene,
25,
7482-7491.
|
 |
|
|
|
|
 |
G.B.Willars
(2006).
Mammalian RGS proteins: multifunctional regulators of cellular signalling.
|
| |
Semin Cell Dev Biol,
17,
363-376.
|
 |
|
|
|
|
 |
H.Clevers
(2006).
Wnt/beta-catenin signaling in development and disease.
|
| |
Cell,
127,
469-480.
|
 |
|
|
|
|
 |
N.Janssens,
M.Janicot,
and
T.Perera
(2006).
The Wnt-dependent signaling pathways as target in oncology drug discovery.
|
| |
Invest New Drugs,
24,
263-280.
|
 |
|
|
|
|
 |
S.A.Chasse,
P.Flanary,
S.C.Parnell,
N.Hao,
J.Y.Cha,
D.P.Siderovski,
and
H.G.Dohlman
(2006).
Genome-scale analysis reveals Sst2 as the principal regulator of mating pheromone signaling in the yeast Saccharomyces cerevisiae.
|
| |
Eukaryot Cell,
5,
330-346.
|
 |
|
|
|
|
 |
C.L.Wei,
T.Miura,
P.Robson,
S.K.Lim,
X.Q.Xu,
M.Y.Lee,
S.Gupta,
L.Stanton,
Y.Luo,
J.Schmitt,
S.Thies,
W.Wang,
I.Khrebtukova,
D.Zhou,
E.T.Liu,
Y.J.Ruan,
M.Rao,
and
B.Lim
(2005).
Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state.
|
| |
Stem Cells,
23,
166-185.
|
 |
|
|
|
|
 |
C.R.McCudden,
M.D.Hains,
R.J.Kimple,
D.P.Siderovski,
and
F.S.Willard
(2005).
G-protein signaling: back to the future.
|
| |
Cell Mol Life Sci,
62,
551-577.
|
 |
|
|
|
|
 |
D.P.Siderovski,
and
F.S.Willard
(2005).
The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits.
|
| |
Int J Biol Sci,
1,
51-66.
|
 |
|
|
|
|
 |
M.D.Castellone,
H.Teramoto,
B.O.Williams,
K.M.Druey,
and
J.S.Gutkind
(2005).
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.
|
| |
Science,
310,
1504-1510.
|
 |
|
|
|
|
 |
M.F.Clarke
(2005).
A self-renewal assay for cancer stem cells.
|
| |
Cancer Chemother Pharmacol,
56,
64-68.
|
 |
|
|
|
|
 |
R.Nusse
(2005).
Wnt signaling in disease and in development.
|
| |
Cell Res,
15,
28-32.
|
 |
|
|
|
|
 |
T.M.Wilkie,
and
L.Kinch
(2005).
New roles for Galpha and RGS proteins: communication continues despite pulling sisters apart.
|
| |
Curr Biol,
15,
R843-R854.
|
 |
|
|
|
|
 |
W.Luo,
H.Zou,
L.Jin,
S.Lin,
Q.Li,
Z.Ye,
H.Rui,
and
S.C.Lin
(2005).
Axin contains three separable domains that confer intramolecular, homodimeric, and heterodimeric interactions involved in distinct functions.
|
| |
J Biol Chem,
280,
5054-5060.
|
 |
|
|
|
|
 |
C.Y.Logan,
and
R.Nusse
(2004).
The Wnt signaling pathway in development and disease.
|
| |
Annu Rev Cell Dev Biol,
20,
781-810.
|
 |
|
|
|
|
 |
J.Choi,
S.Y.Park,
F.Costantini,
E.H.Jho,
and
C.K.Joo
(2004).
Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin.
|
| |
J Biol Chem,
279,
49188-49198.
|
 |
|
|
|
|
 |
L.Xu,
and
J.Massagué
(2004).
Nucleocytoplasmic shuttling of signal transducers.
|
| |
Nat Rev Mol Cell Biol,
5,
209-219.
|
 |
|
|
|
|
 |
M.Al-Hajj,
M.W.Becker,
M.Wicha,
I.Weissman,
and
M.F.Clarke
(2004).
Therapeutic implications of cancer stem cells.
|
| |
Curr Opin Genet Dev,
14,
43-47.
|
 |
|
|
|
|
 |
P.W.Day,
J.J.Tesmer,
R.Sterne-Marr,
L.C.Freeman,
J.L.Benovic,
and
P.B.Wedegaertner
(2004).
Characterization of the GRK2 binding site of Galphaq.
|
| |
J Biol Chem,
279,
53643-53652.
|
 |
|
|
|
|
 |
B.Sun,
and
R.A.Firtel
(2003).
A regulator of G protein signaling-containing kinase is important for chemotaxis and multicellular development in dictyostelium.
|
| |
Mol Biol Cell,
14,
1727-1743.
|
 |
|
|
|
|
 |
D.T.Lodowski,
J.A.Pitcher,
W.D.Capel,
R.J.Lefkowitz,
and
J.J.Tesmer
(2003).
Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma.
|
| |
Science,
300,
1256-1262.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.H.Jin,
Q.J.Shao,
W.Luo,
Z.Y.Ye,
Q.Li,
and
S.C.Lin
(2003).
Detection of point mutations of the Axin1 gene in colorectal cancers.
|
| |
Int J Cancer,
107,
696-699.
|
 |
|
|
|
|
 |
R.Sterne-Marr,
J.J.Tesmer,
P.W.Day,
R.P.Stracquatanio,
J.A.Cilente,
K.E.O'Connor,
A.N.Pronin,
J.L.Benovic,
and
P.B.Wedegaertner
(2003).
G protein-coupled receptor Kinase 2/G alpha q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits.
|
| |
J Biol Chem,
278,
6050-6058.
|
 |
|
|
|
|
 |
T.Wieland,
and
C.Mittmann
(2003).
Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system.
|
| |
Pharmacol Ther,
97,
95.
|
 |
|
|
|
|
 |
H.C.Korswagen,
D.Y.Coudreuse,
M.C.Betist,
S.van de Water,
D.Zivkovic,
and
H.C.Clevers
(2002).
The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans.
|
| |
Genes Dev,
16,
1291-1302.
|
 |
|
|
|
|
 |
M.Bienz
(2002).
The subcellular destinations of APC proteins.
|
| |
Nat Rev Mol Cell Biol,
3,
328-338.
|
 |
|
|
|
|
 |
M.Patturajan,
S.Nomoto,
M.Sommer,
A.Fomenkov,
K.Hibi,
R.Zangen,
N.Poliak,
J.Califano,
B.Trink,
E.Ratovitski,
and
D.Sidransky
(2002).
DeltaNp63 induces beta-catenin nuclear accumulation and signaling.
|
| |
Cancer Cell,
1,
369-379.
|
 |
|
|
|
|
 |
R.R.Neubig,
and
D.P.Siderovski
(2002).
Regulators of G-protein signalling as new central nervous system drug targets.
|
| |
Nat Rev Drug Discov,
1,
187-197.
|
 |
|
|
|
|
 |
Y.Shimizu,
S.Ikeda,
M.Fujimori,
S.Kodama,
M.Nakahara,
M.Okajima,
and
T.Asahara
(2002).
Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.
|
| |
Genes Chromosomes Cancer,
33,
73-81.
|
 |
|
|
|
|
 |
Y.Zhang,
W.J.Qiu,
S.C.Chan,
J.Han,
X.He,
and
S.C.Lin
(2002).
Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways.
|
| |
J Biol Chem,
277,
17706-17712.
|
 |
|
|
|
|
 |
A.Inanobe,
S.Fujita,
Y.Makino,
K.Matsushita,
M.Ishii,
M.Chachin,
and
Y.Kurachi
(2001).
Interaction between the RGS domain of RGS4 with G protein alpha subunits mediates the voltage-dependent relaxation of the G protein-gated potassium channel.
|
| |
J Physiol,
535,
133-143.
|
 |
|
|
|
|
 |
F.Zhang,
R.L.White,
and
K.L.Neufeld
(2001).
Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein.
|
| |
Mol Cell Biol,
21,
8143-8156.
|
 |
|
|
|
|
 |
K.L.Longenecker,
M.E.Lewis,
H.Chikumi,
J.S.Gutkind,
and
Z.S.Derewenda
(2001).
Structure of the RGS-like domain from PDZ-RhoGEF: linking heterotrimeric g protein-coupled signaling to Rho GTPases.
|
| |
Structure,
9,
559-569.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Wang,
R.K.Sunahara,
A.Krumins,
G.Perkins,
M.L.Crochiere,
M.Mackey,
S.Bell,
M.H.Ellisman,
and
S.S.Taylor
(2001).
Cloning and mitochondrial localization of full-length D-AKAP2, a protein kinase A anchoring protein.
|
| |
Proc Natl Acad Sci U S A,
98,
3220-3225.
|
 |
|
|
|
|
 |
Z.Chen,
C.D.Wells,
P.C.Sternweis,
and
S.R.Sprang
(2001).
Structure of the rgRGS domain of p115RhoGEF.
|
| |
Nat Struct Biol,
8,
805-809.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.M.Ross,
and
T.M.Wilkie
(2000).
GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins.
|
| |
Annu Rev Biochem,
69,
795-827.
|
 |
|
|
|
|
 |
K.J.Harrington,
K.N.Syrigos,
and
K.J.Harington
(2000).
The role of E-cadherin-catenin complex: more than an intercellular glue?
|
| |
Ann Surg Oncol,
7,
783-788.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |